1. 1 Suster S, Moran CA: Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 111:826-833, 1999
2. 2 World Health Organization Classification of Tumours. Pathology and Genetics of Tumuors of Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds): 1st ed, Lyon, International Agency for Research on Cancer (IRAC) Press, 2004
3. 3 Pan CC, Chen PC, Chiang H: KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol 202:375-381, 2004
4. 4 Kojika M, Ishii G, Yoshida J, Nishimura M, Hishida T, et al.: Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma : diagnostic utility of hypoxic marker GLUT-1, in thymic epithelial neoplasms. Mod Pathol 22:1341-1350, 2009
5. 5 Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, et al.: CD5 expression in thymic carcinoma. Am J Pathol 145:268-275, 1994